ArticleThe Journal of molecular diagnostics : JMD2021

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry.

Caleb Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.